AU Patent

AU2006269961B2 — Multiple active pharmaceutical ingredients combined in discrete inhalation particles and formulations thereof

Assigned to MAP Pharmaceuticals Inc · Expires 2012-07-19 · 14y expired

What this patent protects

The present disclosure describe inhalation particles where each discrete unagglomerated inhalation particle comprising 2 or more active pharmaceutical ingredients. In one embodiment, the inhalation particles comprise a first and a second API where the second API covers, at least …

USPTO Abstract

The present disclosure describe inhalation particles where each discrete unagglomerated inhalation particle comprising 2 or more active pharmaceutical ingredients. In one embodiment, the inhalation particles comprise a first and a second API where the second API covers, at least partially, and protects the first API from degradation or instability. Inhalation particles comprising a first and a second API as described herein have many advantages over present means of delivering two or more APIs. Formulations comprising such inhalation particles are also described.

Drugs covered by this patent

Patent Metadata

Patent number
AU2006269961B2
Jurisdiction
AU
Classification
—
Expires
2012-07-19
Drug substance claim
No
Drug product claim
No
Assignee
MAP Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.